banner Image
Corporate Profile

ELEVAI Labs Inc., is a California based medical aesthetic biotechnology company that has created and continues to invent innovative science driven efficacious topical skincare technologies for the medical dispense market. ELEVAI® has commercialized ELEVAI Exosomes™ a next generation, patent pending technology used in our ELEVAI® flagship products: ENFINITY™ and EMPOWER™ a patent pending regenerative skincare system for the post treatment market.

ELEVAI Exosomes ™ are generated by mesenchymal stem cells in our own GLP grade laboratories based in the US. ELEVAI Exosomes™ are handled only by trained US based scientists and tested for purity and quality before being used in our skincare formulations. Our exosomes are derived from pure, ethically sourced mesenchymal stem cells derived in a pharmaceutical grade cGMP lab environment.

The ELEVAI® skincare system is currently available in medical aesthetic offices across the US and Canada, with expected growth over 1200 accounts in 2023, plus ELEVAI® will soon to be available outside North America via our distribution partners.

OUR BIG PLAN

The topical skincare industry is dominated by confusing, manipulative marketing claims and products with dated technology with limited or zero real scientific data of efficacy. At ELEVAI® we believe it doesn’t have to be this way and think consumers need better options and skincare products that has been created by real professional scientist, in a lab with properly researched biological technologies. This belief and passion is the genesis to our skincare technologies and has helped us shape start the transformation where skin beauty can be achieved for all ages.


We are revolutionizing the medical aesthetic skincare market with supercharged innovation, efficacious data driven skincare systems built on transparency and science.

  • Continue to invent highly efficacious, data backed next generation exosome skincare products for our medical aesthetic Partner Accounts and consumers across the US and Canada
  • Support and invest heavily in our Sales Agents and our Partner Accounts
  • Continually provide updated data, product education. We believe transparency is the key for us all to provide consumers with the best solutions for their skincare needs
  • Grow our brand awareness and continue to build on our scientific data mantra and drive consumers to our trusted Partner Accounts across the nation
  • Support and build on our global partnerships through the introduction of new products and active support and engagements from our key opinion leaders
  • Hypergrowth by expanding and investing in our sales force and strategic partnerships to expand our footprint
Our Flagship Brand:
ELEVAI Skincare
THE Luxury Award-winning
Exosomes Post Procedure Skincare System
Our Flagship Brand::
ELEVAI Skincare
THE Luxury Award-winning
Exosomes Post Procedure Skincare System
Market Opportunity
$25B
TAM
Global Physician Dispensed Cosmeceutical Market
$9B
SAM
U.S. Physician Dispensed Cosmeceutical Market
$4.5B
SOM
U.S. Physician Dispensed Skincare Market.
2.5% penetration estimated by 2026.
WE ARE ON TRACK TO HIT OUR GOAL AND BE IN OVER 1000 PARTNER MEDICAL PRACTICE ACCOUNTS BY 2024

Integrated Bio
Manufacturing
We operate our own clean GLP laboratory in California